US Patent Issued to Shattuck Labs on Dec. 9 for "Fusion proteins for the treatment of cardiometabolic diseases" (Texas Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,236, issued on Dec. 9, was assigned to Shattuck Labs Inc. (Austin, Texas).

"Fusion proteins for the treatment of cardiometabolic diseases" was invented by Taylor Schreiber (Austin, Texas) and George Fromm (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to, inter alia, compositions and pharmaceutical composition s, including heterologous chimeric proteins that find use, inter alia, in the treatment of diabetes, obesity, or metabolic syndrome."

The patent was filed on April 12, 2024, under Application No. 18/634,496.

*For further information, including images, charts and tables, please visit: http://patft....